GlassScriptPhysician profile
Anwar K Malik
NPI 1407948771
$348.71
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $146 · 2021: $15.04.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $87.09 | 2019-2020 | |
| Philips North America LLC | $70.10 | 2020 | |
| Janssen Pharmaceuticals, INC | $63.20 | 2019 | |
| Novartis Pharmaceuticals Corporation | $36.11 | 2019 | |
| Akcea Therapeutics, INC. | $25.13 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.00 | 2019 | |
| Amarin Pharma, INC. | $17.92 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.04 | 2021 | |
| Edwards Lifesciences Corporation | $14.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anwar Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.